We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Research Examines Gene Therapy To Treat Uterine Fibroids

By LabMedica International staff writers
Posted on 23 Feb 2009
Print article
Investigators have begun using gene therapy to treat uterine fibroids, a condition that is four times more prevalent in African American women than in women from other ethnic groups in the United States.

In an article published in the January 2009 issue of the Fertility and Sterility, the journal of the American Society for Reproductive Medicine, Ayman Al-Hendy, M.D., professor and vice chair of the department of obstetrics and gynecology at Meharry Medical College (Nashville, TN, USA) described his findings. "This condition is a major issue of health disparity because it puts African American women at a huge disadvantage during their most productive years,” said Dr. Al-Hendy.

Uterine fibroids occur in nearly 40% of reproductive age women beginning in their mid-20s and continuing until menopause. The symptoms are often debilitating and include excessive vaginal bleeding, anemia, fatigue, and lack of energy. According to Dr. Al-Hendy, women who suffer from uterine fibroids may lose time from work, have higher medical expenses, and frequently need advanced medical treatment in order to become pregnant, all things that cause both emotional and economic difficulties for families.

Dr. Al-Hendy's research, conducted on experimental animals, revealed that gene therapy treatment could be confined to the benign fibroid tumor without causing damage to the rest of the uterus. Current treatments usually include invasive surgeries that may result in greater scarring and infertility. While further experimentation is needed, Dr. Al-Hendy believes his new approach will offer hope and relief to millions of women.

"If we can achieve our research goal, women will see a greater decrease in their symptoms without the need for surgery and be able to preserve their fertility potential at same time,” Dr. Al-Hendy's noted. His research will continue safety testing in experimental animals; the next step will be to move toward clinical trials.

Meharry Medical College's Center for Women's Health Research is also developing other nonsurgical treatments for uterine fibroids. Clinical trials are currently being conducted using nutritional supplements and other pharmaceuticals for alternative noninvasive treatment for uterine fibroids.

Related Links:
Meharry Medical College



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Drug Test
Instant-view Methadone Urine Drug Test
New
Leishmania Test
Leishmania Real Time PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Small molecule modulation of protein corona significantly enhances deep plasma proteome profiling (Photo courtesy of Mahmoudi Group)

Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes

It has long been established that the earlier a disease is detected, the better the chances for a positive patient outcome. A novel method now offers an in-depth analysis of proteins in plasma, uncovering... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.